Nassir M - Search Results

1

Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.

Braicu EI, Gasimli K, Richter R, Nassir M, Kümmel S, Blohmer JU, Yalcinkaya I, Chekerov R, Ignat I, Ionescu A, Mentze M, Fotopoulou C, Pop C, Lichtenegger W, Sehouli J; Tumor Bank Ovarian Cancer (TOC); German North Eastern Society for Gynecological Oncology (NOGGO). Braicu EI, et al. Among authors: nassir m. Anticancer Res. 2014 Jan;34(1):385-91. Anticancer Res. 2014. PMID: 24403492 Clinical Trial.

2

HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network.

Nassir M, Darb-Esfahani S, Richter R, Chekerov R, Hall C, Muallem MZ, Denkert C, Stamatian F, Fotopoulou C, Sehouli J, Braicu EI. Nassir M, et al. Anticancer Res. 2013 Apr;33(4):1673-7. Anticancer Res. 2013. PMID: 23564814

3

HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse.

Braicu EI, Chekerov R, Richter R, Pop C, Nassir M, Loefgren H, Stamatian F, Muallem MZ, Hall C, Fotopoulou C, Sehouli J, Pietzner K. Braicu EI, et al. Among authors: nassir m. Ann Surg Oncol. 2014 Mar;21(3):955-62. doi: 10.1245/s10434-013-3347-1. Epub 2013 Nov 12. Ann Surg Oncol. 2014. PMID: 24217786

4

Is endometrial cancer really a neurophobic tumor? A case report and review of the literature.

Nassir M, Roth A, Gasimli K, Braicu EI, Fotopoulou C, Mawrin C, Badakhshi H, Warnke JP, Sehouli J. Nassir M, et al. Anticancer Res. 2014 Jan;34(1):249-57. Anticancer Res. 2014. PMID: 24403471 Review.

5

ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer.

Muallem MZ, Braicu I, Nassir M, Richter R, Sehouli J, Arsenic R. Muallem MZ, et al. Among authors: nassir m. Anticancer Res. 2014 Jan;34(1):393-9. Anticancer Res. 2014. PMID: 24403493

6

Preoperative HE4 and ROMA values do not improve the CA125 diagnostic value for borderline tumors of the ovary (BOT) - a study of the TOC Consortium.

Braicu EI, Van Gorp T, Nassir M, Richter R, Chekerov R, Gasimli K, Timmerman D, Vergote I, Sehouli J. Braicu EI, et al. Among authors: nassir m. J Ovarian Res. 2014 May 7;7:49. doi: 10.1186/1757-2215-7-49. eCollection 2014. J Ovarian Res. 2014. PMID: 24872845 Free PMC article.

7

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab.

Seeber A, Braicu I, Untergasser G, Nassir M, Fong D, Botta L, Gastl G, Fiegl H, Zeimet A, Sehouli J, Spizzo G. Seeber A, et al. Among authors: nassir m. Oncotarget. 2015 Sep 22;6(28):25017-23. doi: 10.18632/oncotarget.4496. Oncotarget. 2015. PMID: 26296970 Free PMC article.

8

The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.

Nassir M, Guan J, Luketina H, Siepmann T, Rohr I, Richter R, Castillo-Tong DC, Zeillinger R, Vergote I, Van Nieuwenhuysen E, Concin N, Marth C, Hall C, Mahner S, Woelber L, Sehouli J, Braicu EI. Nassir M, et al. Tumour Biol. 2016 Mar;37(3):3009-16. doi: 10.1007/s13277-015-4031-9. Epub 2015 Sep 29. Tumour Biol. 2016. PMID: 26419591

9

Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.

Gasimli K, Braicu EI, Nassir M, Richter R, Babayeva A, Chekerov R, Darb-Esfahani S, Sehouli J, Muallem MZ. Gasimli K, et al. Among authors: nassir m. Ann Surg Oncol. 2016 Apr;23(4):1279-86. doi: 10.1245/s10434-015-4959-4. Epub 2016 Jan 29. Ann Surg Oncol. 2016. PMID: 26832880

10

Role of IGF-I in Primary Ovarian Cancer - A Study of the OVCAD European Consortium.

Rohr I, Zeillinger R, Heinrich M, Concin N, Vergote I, Nassir M, Mahner S, VAN Nieuwenhuysen E, Trillsch F, Cacsire-Tong D, Chekerov R, Sehouli J, Braicu EI. Rohr I, et al. Among authors: nassir m. Anticancer Res. 2016 Mar;36(3):1015-22. Anticancer Res. 2016. PMID: 26976992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters